Charles Schwab Investment Management Inc Biote Corp. Transaction History
Charles Schwab Investment Management Inc
- $527 Billion
- Q4 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Biote Corp. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 75,738 shares of BTMD stock, worth $344,607. This represents 0.0% of its overall portfolio holdings.
Number of Shares
75,738
Previous 70,523
7.39%
Holding current value
$344,607
Previous $393,000
20.61%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding BTMD
# of Institutions
86Shares Held
17.8MCall Options Held
0Put Options Held
0-
325 Capital LLC New York, NY4.55MShares$20.7 Million13.05% of portfolio
-
Bandera Partners LLC New York, NY2.44MShares$11.1 Million5.13% of portfolio
-
Black Rock Inc. New York, NY1.61MShares$7.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.42MShares$6.45 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT1.39MShares$6.34 Million0.04% of portfolio
About biote Corp.
- Ticker BTMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Care Facilities
- Shares Outstandng 7,574,270
- Market Cap $34.5M
- Description
- biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biot...